Skip to navigation Skip to content
  • The Cancer Letter on Facebook
  • The Cancer Letter on Twitter
  • The Cancer Letter on LinkedIn

The Cancer Letter

The leading source for information on the issues that shape oncology since 1973

Home
  • About
    • Our Readers
    • Our History
    • Our Contributors
    • Contact Us
    • Store
  • Current Issue
    • Past Issues
  • Podcast
    • The Directors
  • Events
  • Job Board
  • SUBSCRIBE
  • Login
  • SUBSCRIBE
  • Login
The Cancer Letter
Home
  • About
    • Our Readers
    • Our History
    • Our Contributors
    • Contact Us
    • Store
  • Current Issue
    • Past Issues
  • Podcast
    • The Directors
  • Events
  • Job Board
Cancer Policy

$180M in NCI grants have been terminated by Trump administration, systematic review finds

May 09, 2025
Vol.51 No.18
By Jacquelyn Cobb
Clinical Roundup

Incidence rates of some cancer types have risen in people under age 50, NCI study shows

May 09, 2025
Vol.51 No.18
NIH eliminates the NCI Board of Scientific Advisors
News Analysis

NIH eliminates the NCI Board of Scientific Advisors
Over its 28 year history, BSA shaped NCI-funded extramural science

May 02, 2025
Vol.51 No.17
By Paul Goldberg
Bertagnolli: NIH funding cuts are “unprecedented and harmful”

Bertagnolli: NIH funding cuts are “unprecedented and harmful”
AACR panel challenges scientists to find stability in a period of “ventricular tachycardia”

May 02, 2025
Vol.51 No.17
By Claire Marie Porter
Cancer Policy

HHS ordered to cut 35% of spending on contracts

May 02, 2025
Vol.51 No.17
By Jacquelyn Cobb
David Ryan named president of Mass General Brigham Cancer Institute
In Brief

David Ryan named president of Mass General Brigham Cancer Institute

May 02, 2025
Vol.51 No.17
Steven Libutti tells us about building a $900 million cancer hospital for Rutgers RWJBarnabas Health
Conversation with The Cancer Letter

Steven Libutti tells us about building a $900 million cancer hospital for Rutgers RWJBarnabas Health

April 25, 2025
Vol.51 No.16
By Paul Goldberg
Makary vows to speed up drug approvals and end FDA’s “cozy” relationship with industry
Regulatory News

Makary vows to speed up drug approvals and end FDA’s “cozy” relationship with industry
Commissioner promises to protect scientific integrity while bringing in “fresh” MAHA ideas

April 25, 2025
Vol.51 No.16
By Claire Marie Porter
In the Headlines: What’s in Trump’s draft budget?
Podcast

In the Headlines: What’s in Trump’s draft budget?

April 23, 2025
Vol.51 No.15
The Directors: Louis Weiner and Taofeek Owonikoko on keeping up morale amid uncertainty
PodcastThe Directors

The Directors: Louis Weiner and Taofeek Owonikoko on keeping up morale amid uncertainty
“We are resolute. We are committed to continuing to move the work forward.”

April 18, 2025
Vol.51 No.15
By Paul Goldberg

Posts navigation

Previous1…91011…40Next

Trending Stories

  • Is it time to re-assess the practice and practicality of screening colonoscopy?
    Modeling data, ACS guideline support greater use of noninvasive tests to ease system strain, help save lives
  • Michael Caputo appointed to President’s Cancer Panel
    The cancer survivor and political operative says his appointment signals Trump’s interest in cancer, survivorship
  • The Galleri MCD vote: What FDA asked its advisors to ignore
  • From “default dead” to living the future of cancer care
    As founding CEO of GitLab, I went “founder mode” on my osteosarcoma
  • FDA advisory committee votes in favor of Galleri approval, but calls for removal of “early” detection claims
    Clinical benefit will not be considered for approval, FDA says
  • The Directors: Two Gulf Coast cancer center directors on why NCI designation matters—and why they want it
    Lucio Miele and Raghu Kalluri: Science and technology have changed what an aspiring cancer center must accomplish

ABOUT
ABOUT
About The Cancer Letter
Accessibility Statement
Our Contributors
Editorial policies
Store
SUBSCRIPTIONS
SUBSCRIPTIONS
Our readers
Pricing
News alerts
About IP login
Job board
CONTACT
CONTACT
Contact us
Submission guidelines
Advertise
Careers
SEE ALSO
Cancer History Project
The Cancer Letter
Copyright © 2026 The Cancer Letter Inc. All rights reserved.
Privacy Policy
Terms & Conditions
FOLLOW US
Instagram
Twitter
LinkedIn
Facebook
Vimeo
Scroll to top
Request Cancellation

Subscription Change

This change will be effective immediately and your card will be charged a prorated amount based on your existing subscription level.

OK Cancel

Renew today!

Your subscription has lapsed. Subscribe today to access this content.
SUBSCRIBE NOW

Subscriber content

Log in or subscribe to access The Cancer Letter.
LOGINSUBSCRIBE NOW
SEARCH DATE
SEARCH TEXT
      Cancel
      OK
      Cancel
      OK
      Delete Account
      Are you sure you want to delete your account? This will erase all of your account data from the site. To delete your account enter your password below
      No

      Never miss an issue!

      Get alerts for our award-winning coverage in your inbox.

      Login

       
      Forgot Password?

      Site license subscribers:
      Log in with your IP | Register a sponsored account